PLYX — POLARYX THERAPEUTICS, INC. COMMON STOCK (Healthcare >> Biotechnology)
PLYX FAQ
What is PLYX's ROE?
POLARYX THERAPEUTICS, INC. COMMON STOCK reports a Return on Equity (ROE) of -260.33%.
What is PLYX's dividend yield?
POLARYX THERAPEUTICS, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is PLYX's Deepscope Quality Score?
Deepscope rates PLYX's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy PLYX?
Deepscope's AI Timing Score for PLYX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does PLYX belong to?
POLARYX THERAPEUTICS, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.34
Price
-0.03
(-1.27%)
Day Change
|
|
|---|
PLYX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 38) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
44% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.34 |
| PBV / Sector |
47.48 / 4.90
|
| Earning Per Share | -0.13 |
| PE / Sector |
N/A / 18.25
|
| PEG or PE/Growth / Sector |
N/A / 0.62
|
| Average 1M Daily Value |
1.11 M
GREAT
|
| Average 1W Daily Value |
0.34 M
GREAT
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
50% |
| Khả năng kiếm lợi nhuận |
|
37% |
| Lợi tức cho nhà đầu tư |
|
8% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-16 09:59:10 |
| Symbol | PLYX |
| Name | POLARYX THERAPEUTICS, INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 49.85 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 118.13 / 8,995.97 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: South Tower, Paramus, NJ, United States, 07652
Phone: 201 940 7236
Website: https://polaryx.com
Sector: Healthcare >> Biotechnology
Description: Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google